| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Spero Therapeutics Inc (NASDAQ: SPRO)
SPRO Technical Analysis
5
| As on 9th Jun 2023 SPRO STOCK Price closed @ 1.78 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.63 & Strong Sell for SHORT-TERM with Stoploss of 11.48 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SPROSTOCK Price
| Open | 1.79 | Change | Price | % |
| High | 1.81 | 1 Day | -0.02 | -1.11 |
| Low | 1.76 | 1 Week | 0.04 | 2.30 |
| Close | 1.78 | 1 Month | 0.00 | 0.00 |
| Volume | 115610 | 1 Year | -12.04 | -87.12 |
| 52 Week High 16.01 | 52 Week Low 0.68 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SPRO Daily Charts |
SPRO Intraday Charts |
Whats New @ Bazaartrend |
SPRO Free Analysis |
|
|
SPRO Important Levels Intraday
| RESISTANCE | 1.88 |
| RESISTANCE | 1.85 |
| RESISTANCE | 1.83 |
| RESISTANCE | 1.81 |
| SUPPORT | 1.75 |
| SUPPORT | 1.73 |
| SUPPORT | 1.71 |
| SUPPORT | 1.68 |
SPRO Forecast April 2024
| 4th UP Forecast | 10.16 |
| 3rd UP Forecast | 7.47 |
| 2nd UP Forecast | 5.81 |
| 1st UP Forecast | 4.15 |
| 1st DOWN Forecast | -0.59 |
| 2nd DOWN Forecast | -2.25 |
| 3rd DOWN Forecast | -3.91 |
| 4th DOWN Forecast | -6.6 |
SPRO Weekly Forecast
| 4th UP Forecast | 7.72 |
| 3rd UP Forecast | 5.81 |
| 2nd UP Forecast | 4.64 |
| 1st UP Forecast | 3.46 |
| 1st DOWN Forecast | 0.10 |
| 2nd DOWN Forecast | -1.08 |
| 3rd DOWN Forecast | -2.25 |
| 4th DOWN Forecast | -4.16 |
SPRO Forecast2024
| 4th UP Forecast | 31.88 |
| 3rd UP Forecast | 22.23 |
| 2nd UP Forecast | 16.26 |
| 1st UP Forecast | 10.29 |
| 1st DOWN Forecast | -6.73 |
| 2nd DOWN Forecast | -12.7 |
| 3rd DOWN Forecast | -18.67 |
| 4th DOWN Forecast | -28.32 |
Spero Therapeutics Inc ( NASDAQ USA Symbol : SPRO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SPRO Business Profile
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. Its product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat MDR gram-negative infections for adults; SPR206, a direct acting IV-administered agent to treat MDR Gram-negative bacterial infections in the hospital; and SPR720, an oral antibiotic for the treatment of non-tuberculous mycobacterial pulmonary disease. Spero Therapeutics, Inc. has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; license agreement with Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; collaboration agreement with Bill & Melinda Gates Medical Research Institute to develop SPR720 for the treatment of lung infections caused by Mycobacterium tuberculosis; and license agreement with Vertex Pharmaceuticals Incorporated for patents relating to SPR720, as well as SPR719, an active metabolite. The company is headquartered in Cambridge, Massachusetts. Address: 675 Massachusetts Avenue, Cambridge, MA, United States, 02139
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service